CapVest Partners, the private-equity fund led by the Irish dealmaker Seamus Fitzpatrick, is acquiring a majority stake in German pharmaceutical company Stada Arzneimittel AG, in a transaction that values the business at €10 billion including debt. In a statement this morning, CapVest said it had signed a definitive agreement to acquire the controlling stake from Bain Capital and Cinven, two other private equity firms who will continue to hold minority stakes in the business. Founded in 1999, this is the largest ever deal by CapVest, which is best known in Ireland as the previous owner of the Mater Private hospital…

Want to continue reading?

Join today with an Annual membership and get full access to The Currency for just €200 (68c per day) or try monthly membership for just €5 for your first month.

Subscribe

Cancel at any time.

Are you already a member? .